壳聚糖/乙酰半胱氨酸纳米粒子的性质及体外释药性

制备了一种基于壳聚糖/乙酰半胱氨酸偶合物(CS-NAC)的新型巯基纳米粒子并进行了结构表征, 同时对纳米粒子的黏附性、溶胀性和药物释放进行了测试. 结果表明, 纳米粒子具有较小的粒径(140~210 nm)和正的表面电位(19.5~31.7 mV), 胰岛素的载药量达到13%~42%. 这些性质随着巯基含量的变化而变化. 与壳聚糖纳米粒子相比, 巯基壳聚糖纳米粒子表现出了更强更快的黏附性质. 体外释放研究结果表明, 巯基壳聚糖纳米粒子的胰岛素释放具有pH响应性. 在pH=6.8时, 15 min即能释放58.6 %的胰岛素; 而在pH=5.4时, 24 h内仅有不到40%的胰岛素被释放. 因此, CS-NAC纳米粒子用于胰岛素的黏膜给药体系具有很好的应用前景.     

新型生物粘附性材料——巯基聚合物粘附性和促吸收性研究进展

巯基粘附性聚合物利用二硫键的形成,以共价的方式粘附于鼻腔、口腔以及胃肠等粘膜表面,延长药物在粘膜上滞留时间,而且能提高药物对细胞膜的透过性,有利于药物分子吸收.因此,巯基粘附性聚合物作为新型给药载体材料具有很好的应用前景,近年来备受关注.巯基聚合物这种优良的性能与其具有高的粘附性和好的促吸收性能是分不开的.本文就巯基聚合物的粘附性能和促吸收作用机制及其影响因素进行了综述,旨在能够较全面认识这种粘附性材料,为开发新型生物粘附给药系统提供新的思路和方法.     

巯基化壳聚糖/明胶的制备研究

仿生杂化构建可注射水凝胶支架是制备组织工程材料的一条有效途径,而天然聚合物的改性即成为其前提条件。本文以巯基乙酸和4-丁巯内酯为反应试剂采用均相反应法制备了巯基化天然聚合物衍生物。结果表明,利用壳聚糖和明胶上的氨基等活性基团,可采用不同途径对它们进行巯基化改性;在水溶性碳二亚胺的活化作用下巯基乙酸的羧基与壳聚糖的氨基形成酰胺键,从而将活性巯基引入到壳聚糖中,但大部分被氧化;随着贮存时间的延长,各改性物中的巯基含量逐渐降低,因此需将改性物保存于低温惰性环境中,以保持其反应活性。     

动态硼酸酯键管控邻苯二酚基团与功能黏附性高分子设计

“黏附”是一种普遍存在的多尺度相互作用,其实质是界面处化学键、氢键或范德华力等的形成.近年来,在贻贝仿生的基础上将黏性因子邻苯二酚基团嵌入到动态硼酸酯聚合物中,成为了功能黏附性高分子的重要发展方向.本专论从分子黏附、微/纳表面黏附和宏观表面黏附3个尺度,介绍硼酸酯键管控邻苯二酚基团在高分子材料功能化方面的研究进展.分子黏附,主要讨论硼酸酯聚合物中邻苯二酚基团与分子或离子相互作用规律及其对材料形貌和刺激响应性能的调控;微/纳表面黏附,论述硼酸酯聚合物体系超分子驱动力和组装机制,介绍其在微/纳材料功能化改性方面的研究进展;宏观表面黏附,讨论硼酸酯键管控邻苯二酚基团与黏附性能调控的关联规律,介绍硼酸酯聚合物功能黏附材料在宏观组装、攀爬机器人领域的应用.最后,从新型硼酸酯聚合物设计、动态键精准管控和器件化应用的角度,对该领域未来前景和发展趋势做出了展望.     

含巯基/二硫键聚合物生物材料

含巯基/二硫键聚合物生物材料具有多种良好的性能,作为药物、基因等的释放载体在生物医学领域具有广泛的应用前景。随着基因工程和组织工程的发展,含巯基/二硫键聚合物生物材料的可生物降解性得到高度重视,而怎样改善其降解性能成为限制其应用的关键因素。由于二硫键在细胞外环境里保持稳定,在细胞溶质的还原环境中容易发生断裂,因此在制备新型基因、药物等释放载体上,二硫键充当了重要的角色,它的引入为聚合物生物材料的生物降解性能的设计与改善提供了一条重要的途径。本综述重点以聚合物水凝胶、聚合物微胶束、囊泡等为例,从巯基/烯的光聚合反应、Michael加成反应、氧化还原反应的角度,介绍了巯基/烯在聚合物中形成二硫键的不同途径的研究进展,并详细论述了基因载体、蛋白质载体、小分子药物载体三种还原敏感型材料的制备、表面修饰和改性的进展情况,进一步强调含巯基/二硫键聚合物生物材料的研究在生物医学领域应用的重要性。     

纳米Eu2O3/硫酸酯化壳聚糖杂化材料的制备及其抗凝血性能研究

利用表面接枝的方法制备了纳米Eu2 O3/硫酸酯化壳聚糖杂化材料,并用IR,TG和SEM等方法对产物进行了表征,结果表明硫酸酯化壳聚糖接枝在了经过活化后的纳米氧化物表面,细胞毒性实验证明材料具有较低的细胞毒性和较好的细胞相容性.抗凝血实验说明材料具有良好的抗凝血性能.表面接枝方法提高了壳聚糖类化合物的抗凝作用,弥补了比...     

海藻酸钠和壳聚糖静电复合弹性支架的制备和表征

通过静电作用和相分离技术制备海藻酸钠/壳聚糖静电复合弹性支架,研究了冷冻温度和固含量对支架材料孔径的影响及组分比对材料力学性能、亲水性、降解性能和生物相容性的影响.固含量为2%(质量分数)及冷冻温度为-24℃时,支架孔径为110~170μm,并且亲水性良好,平衡溶胀度大于1400%.改变固含量和组分比可调控材料的力学性能;循环力学测试表明,湿态支架具有良好的弹性和一定的耐疲劳性;降解速率可由组分比调控;兔脂肪干细胞(rASCs)在支架上的培养结果表明,羧基和氨基摩尔比为2∶1和1∶1时细胞以聚集体存在;羧基和氨基摩尔比为1∶2时细胞黏附于支架上,实现细胞黏附/聚集体的调控.     

仿细胞外层膜结构修饰交联壳聚糖的研究

采用溶液自由基聚合,合成甲基丙烯酰氧乙基磷酰胆碱(MPC)-甲基丙烯酰氧丙基三甲氧基硅(TSMA)二元共聚物(PMT82),将其涂覆在戊二醛交联壳聚糖(CS-GA)表面,通过三乙胺蒸汽催化处理获得具有仿细胞外层膜结构(CS-GA-PMT82b)的表面.用动态接触角(DCA)、X-射线光电子能谱(XPS)对改性后交联壳聚糖表面的亲疏水性、元素组成等进行表征,并通过血小板黏附实验对其抗凝血性进行评价.研究结果表明,这种利用涂覆催化交联的方式将含有三甲氧基硅可交联基团的磷酰胆碱聚合物交联固定在壳聚糖表面,获得了较为稳定的仿细胞外层膜结构的CS-GA-PMT82b涂层表面.与壳聚糖相比,改性后壳聚糖的血小板黏附显著减少,抗凝血性能显著提高.这种改善材料的方式有望成为生物医用材料表面改性领域的有效的新手段.     

形状记忆聚合物表面微结构及黏附性能的可逆调控

采用模板法在形状记忆聚合物表面构筑了微纳米等级结构,获得了一种具有低黏附性的超疏水表面.在外压作用下,表面微结构发生坍塌,失去超疏水性,同时呈高黏附性.在120℃热处理后,表面微结构恢复到原始状态,同时表面恢复到低黏附状态.通过外压及热处理过程可实现对表面微结构及其黏附性能的可逆调控.研究结果表明,表面不同的微结构状态赋予了表面不同的黏附性能,即在原始表面上,液滴处于低黏附的Cassie态,而在坍塌结构表面上水滴处于高黏附的Wenzel态.     

光聚合水凝胶及其在组织工程中的应用

水凝胶是一种亲水性聚合物网络,可以溶胀大量水,其物理性质接近软组织.光聚合与传统的聚合方法相比,具有反应速率快、反应条件缓和、反应放热低等特点.因此,光聚合水凝胶广泛应用于生物医学领域.本文介绍了光聚合水凝胶材料,并详细论述了光聚合水凝胶在药物释放体系、组织工程支架材料、细胞受控生长、细胞微囊化和可注射水凝胶等方面的应用.可以预见光聚合水凝胶作为生物材料在组织工程及再生医学领域中具有良好的应用前景.     

Thiolated mucoadhesive and PEGylated nonmucoadhesive organosilica nanoparticles from 3-mercaptopropyltrimethoxysilane

A novel approach has been developed to synthesize thiolated sub-100 nm organosilica nanoparticles from 3-mercaptopropyltrimethoxysilane (MPTS) through its self-condensation in dimethylsulfoxide in contact with atmospheric oxygen. The formation of MPTS nanoparticles proceeds through the condensation of methoxysilane groups and simultaneous disulfide bridging caused by partial oxidation of thiol groups. These nanoparticles showed excellent colloidal stability in dilute aqueous dispersions but underwent further self-assembly into chains and necklaces at higher concentrations. They exhibited very good ability to adhere to ocular mucosal surfaces, which can find applications in drug delivery. The thiolated nanoparticles could also be easily modified through PEGylation resulting in a loss of their mucoadhesive properties.     

In vitro evaluation of mucoadhesive vaginal tablets of antifungal drugs prepared with thiolated polymer and development of a new dissolution technique for vaginal formulations

The main objective of this work was to develop antifungal matrix tablet for vaginal applications using mucoadhesive thiolated polymer. Econazole nitrate (EN) and miconazole nitrate (MN) were used as antifungal drugs to prepare the vaginal tablet formulations. Thiolated poly(acrylic acid)-cysteine (PAA-Cys) conjugate was synthesized by the covalent attachment of L-cysteine to PAA with the formation of amide bonds between the primary amino group of L-cysteine and the carboxylic acid group of the polymer. Vaginal mucoadhesive matrix tablets were prepared by direct compression technique. The investigation focused on the influence of modified polymer on water uptake behavior, mucoadhesive property and release rate of drug. Thiolated polymer increased the water uptake ratio and mucoadhesive property of the formulations. A new simple dissolution technique was developed to simulate the vaginal environment for the evaluation of release behavior of vaginal tablets. In this technique, daily production amount and rate of the vaginal fluid was used without any rotational movement. The drug release was found to be slower from PAA-Cys compared to that from PAA formulations. The similarity study results confirmed that the difference in particle size of EN and MN did not affect their release profile. The release process was described by plotting the fraction released drug versus time and n fitting data to the simple exponential model: M(t)/M(∞)=kt(n). The release kinetics were determined as Super Case II for all the formulations prepared with PAA or PAA-Cys. According to these results the mucoadhesive vaginal tablet formulations prepared with PAA-Cys represent good example for delivery systems which prolong the residence time of drugs at the vaginal mucosal surface.     

Synthesis and biological evaluation of disulfide-linked HPMA copolymer-mesochlorin e6 conjugates

Novel polymeric delivery systems for the photosensitizer mesochlorin e6 (Mce6) were synthesized to overcome problems of systemic toxicity. A disulfide bond was included to allow for quick release of Mce6 from the N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer backbone once internalized in tumor tissue. The synthesized conjugates demonstrated a time-dependent reductive cleavage with an accompanying increase in the quantum yield of singlet oxygen generation on exposure to DTT. Quicker release kinetics and a higher cytotoxicity in SKOV-3 human ovarian carcinoma cells were obtained as compared to polymer conjugate with a proteolytically cleavable GFLG spacer. These novel conjugates hold promise as clinically relevant drug delivery systems for photodynamic therapy of cancer.     

Hybridization and Melting Behavior of Peptide Nucleic Acid (PNA) Oligonucleotide Chimeras Conjugated to Gold Nanoparticles

Peptide nucleic acids (PNA) and PNA–DNA chimeras carrying thiol groups were used for surface functionalization of Au nanoparticles. Conjugation of PNA to citrate‐stabilized Au nanoparticles destabilized the nanoparticles causing them to precipitate. Addition of a tail of glutamic acid to the PNA prevented destabilization of the nanoparticles but resulted in loss of interaction with complementary sequences. Importantly, PNA–DNA chimeras gave stable conjugates with Au nanoparticles. The hybridization and melting properties of complexes formed from chimera–nanoparticle conjugates and oligonucleotide–nanoparticle conjugates are described for the first time. Similar to oligonucleotide–nanoparticle conjugates, conjugates with PNA–DNA chimeras gave sharper and more‐defined melting profiles than those obtained with unmodified oligonucleotides. In addition, mismatch discrimination was found to be more efficient than with unmodified oligonucleotides.     

Evaluation of the DNA Alkylation Properties of a Chlorambucil-Conjugated Cyclic Pyrrole-Imidazole Polyamide

Hairpin pyrrole-imidazole polyamides (hPIPs) and their chlorambucil (Chb) conjugates (hPIP-Chbs) can alkylate DNA in a sequence-specific manner, and have been studied as anticancer drugs. Here, we conjugated Chb to a cyclic PIP (cPIP), which is known to have a higher binding affinity than the corresponding hPIP, and investigated the DNA alkylation properties of the resulting cPIP-Chb using the optimized capillary electrophoresis method and conventional HPLC product analysis. cPIP-Chb conjugate 3 showed higher alkylation activity at its binding sites than did hPIP-Chb conjugates 1 and 2 . Subsequent HPLC analysis revealed that the alkylation site of conjugate 3 , which was identified by capillary electrophoresis, was reliable and that conjugate 3 alkylates the N3 position of adenine as do hPIP-Chbs. Moreover, conjugate 3 showed higher cytotoxicity against LNCaP prostate cancer cells than did conjugate 1 and cytotoxicity comparable to that of conjugate 2 . These results suggest that cPIP-Chbs could be novel DNA alkylating anticancer drugs.     

The formation of conjugates with PEG–chitosan improves the biocatalytic efficiency and antitumor activity of L-asparaginase from <Emphasis Type="Italic">Erwinia carotovora</Emphasis>

The ChitoPEGylation method, which is a novel approach to regulating the catalytic properties of enzymes that is based on the formation of a covalent conjugate of an enzyme with branched copolymers of chitosan, has been developed. The efficiency of this method has been demonstrated using a new recombinant preparation of L-asparaginase from Erwinia carotovora (EwA) as a model. The molecular architecture and composition of EwA conjugates with PEG–chitosans have been optimized. It has been shown that the decisive factors that affect the activity of the EwA conjugates are the molecular weight of and PEGylation degree of chitosan. It has been found that the EwA conjugation with PEG–chitosan increases, its cytostatic activity against human chronic myeloid leukemia K562 cells, Burkitt’s lymphoma Raji cells, and acute lymphoblastic leukemia Jurkat cells. These data provide new approaches to the synthesis of L-asparaginase preparations with improved biocatalytic properties.     

PLGA, chitosan or chitosan-coated PLGA microparticles for alveolar delivery? A comparative study of particle stability during nebulization

Various types of rifampicin (RIF)-loaded microparticles were compared for their stability during nebulization. Poly(lactide-co-glycolide) (PLGA), chitosan (CHT) and PLGA/CHT microparticles (MPs) were prepared by emulsion or precipitation techniques. MPs ability to be nebulized (NE%) as well as stability during freeze-drying or/and nebulization (NEED%), were evaluated after RIF extraction from MPs and determination by light spectroscopy. MP mean diameters and ζ-potential values were measured by dynamic light scattering, morphology was assessed by SEM, cytotoxicity by MTT method and mucoadhesive properties by mucin association.

In all cases, freeze-drying prior to nebulization did not affect EE%, NE or NEED%. In CHT, MPs RIF encapsulation efficiency (EE%) decreased with increasing CHT concentration (viscosity) and CHT-MP NEED% was higher when the polymer was crosslinked by glutaraldehyde. PLGA MPs, exhibited both higher RIF EE% and also higher nebulization ability and NEED%, compared to CHT ones, but also higher cytotoxicity. However, when the two polymers were combined in the PLGA/CHT MPs, EE%, NE% and NEED% increased with increasing MP CHT-content. PLGA/CHT MPs with 0.50% or 0.75% CHT exhibited highest EE% for RIF and also best nebulization ability and stability, compared to all other MP formulations studied. Additionally they had good mucoadhesive properties and comparably low cytotoxicity.     

Interactions between chitosan-modified particles and mucin-coated surfaces

Lipid-based particles (Cubosome particles) were surface-modified by chitosan and the ratio between particles and chitosan was optimized to minimize the free chitosan concentration in the dispersion. The modified particles were characterized by electrophoretic measurements and the pH dependence of the zeta potential could be directly related to the protonation of chitosan. Interaction between the modified particles and mucin-coated silica surfaces were subsequently investigated in situ by ellipsometry to assess the mucoadhesive properties at physiologically relevant conditions. The result showed that a substantial amount of modified particles was adsorbed to mucin-coated silica surfaces at both pH 4 and pH 6, probably due to electrostatic interactions between amino groups in chitosan and negatively charged groups in mucin. Furthermore, the amount of bound particles decreased by less than 15% upon rinsing indicating relatively strong interactions. This investigation demonstrates that ellipsometry is a useful tool to study mucoadhesive properties of particles in the submicrometer range. Moreover, the novel chitosan-modified particles may be of interest for mucosal drug delivery applications.